231 filings
Page 9 of 12
6-K
knk2h43vrwbpmy
23 Jun 20
Annual and Special General Meeting of Shareholders
9:06am
6-K
znft 4zu5
4 Jun 20
Report of Foreign Private Issuer
9:13am
6-K
yqr tjg948zw
19 May 20
Share Transfer Agreement
5:18pm
6-K
w549moct s1
8 May 20
Therapix Biosciences Appoints Prof. Ari Shamiss (M.D., M.P.A.) to the Company’s Board of Directors
6:04am
6-K
8z492rbo0 7ed15
30 Apr 20
Current report (foreign)
4:26pm
6-K
iuxlfco6sv6
28 Apr 20
Current report (foreign)
8:37am
6-K
izv1d3qp7de kn
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
6-K
1shbfsx7
24 Mar 20
Therapix Biosciences Ltd. Signs Securities Purchase Agreement
12:00am
6-K
pn67mud2 c3p
3 Mar 20
Therapix Biosciences Ltd. Receives Nasdaq Notification Regarding Minimum Bid Requirements
9:00am
6-K
fi02qg7 hh1v07hazuvo
7 Feb 20
Report of Foreign Private Issuer
7:38am
6-K
v8esv2b ip6nn9v
22 Jan 20
Current report (foreign)
4:25pm
6-K
gqo09
8 Jan 20
Report of Foreign Private Issuer
4:14pm
6-K
uce0g8b gw5ztsc
2 Jan 20
Report of Foreign Private Issuer
9:31am
6-K
69z7nbgd
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
6-K
06k tgh5yj4t7k
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
axb6t47w7vz4f3e2t 3m
3 Dec 19
Current report (foreign)
12:00am
6-K
wdx9b3wfcj
26 Nov 19
Report of Foreign Private Issuer
4:01pm
6-K
a1m79bqajd1ake2rxblx
19 Nov 19
Report of Foreign Private Issuer
8:33am
6-K
ohk7y97
13 Nov 19
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
4:07pm
6-K
wqggmdrbg8c9dqtn84c
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm